Back
United Therapeutics Stock Predictions
Sponsored
UTHR
Sponsored
Do you own any of the "SELL" rated stocks on this list?
Go here now to get free instant access to all 20 stocks to sell.
Buy
55
UTHR
United Therapeutics
Last Price:
357.80
Seasonality Move:
2.3%
7 Day Trial
ALL ACCESS PASS
$
7
Alex Green's "Next Magnificent Seven" AI Stocks-Turn $7,000 into $1 Million!
Watch Alex's presentation and discover the AI stocks set to dominate!United Therapeutics Stock Forecast
- Over the next 52 weeks, United Therapeutics has on average historically risen by 26% based on the past 25 years of stock performance.
- United Therapeutics has risen higher in 18 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 72%
-
Is United Therapeutics Stock Undervalued?
The current United Therapeutics [UTHR] share price is $355.59. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal. - UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will United Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, United Therapeutics has on average historically risen by 26% based on the past 25 years of stock performance.
United Therapeutics Stock Rating
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics overpriced?
- United Therapeutics has risen higher in 18 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 72%
United Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
unither.com
52-Week Data
52-Week High:
366.08
52-Week Low:
208.62
Prediction Charts
Market Cap:
15.82B
Price in USD:
355.59
Volume:
410.04K
Beta:
0.53
Technical Analysis
SMA50:
339.03
SMA100:
313.38
SMA200:
271.32
52-Wk Change:
59.64%
Stock Predictions
-
Is United Therapeutics stock public?
Yes, United Therapeutics is a publicly traded company. -
What is the United Therapeutics stock quote today?
The United Therapeutics stock price is 355.59 USD today. -
How to buy United Therapeutics stock online?
You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-4 | 352.65 | 353.37 | 354.95 | 349.57 |
Sep-5 | 351.29 | 350.24 | 353.01 | 347.62 |
Sep-6 | 349.76 | 345.66 | 351.64 | 345.33 |
Sep-9 | 345.41 | 348.71 | 349.35 | 344.02 |
Sep-10 | 348.10 | 342.46 | 348.10 | 340.46 |
Sep-11 | 343.00 | 346.19 | 347.21 | 340.00 |
Sep-12 | 345.77 | 341.11 | 345.77 | 340.65 |
Sep-13 | 341.69 | 339.12 | 347.29 | 337.52 |
Sep-16 | 339.12 | 344.98 | 345.47 | 338.41 |
Sep-17 | 341.92 | 345.02 | 353.63 | 341.92 |
Sep-18 | 344.57 | 342.59 | 347.57 | 342.03 |
Sep-19 | 345.46 | 351.33 | 353.04 | 344.47 |
Sep-20 | 349.11 | 353.01 | 354.70 | 349.11 |
Sep-23 | 354.04 | 355.59 | 360.00 | 354.00 |
United Therapeutics Earnings
United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
United Therapeutics Forecast Revenue Growth
United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $1.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.87 per share, and an increase next year of $1.42 per share.
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.